NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future | Journal of Medicinal Chemistry
![BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression | Cell Death & Disease BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-022-05497-y/MediaObjects/41419_2022_5497_Fig1_HTML.png)
BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression | Cell Death & Disease
![IJMS | Free Full-Text | Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer IJMS | Free Full-Text | Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer](https://www.mdpi.com/ijms/ijms-23-10479/article_deploy/html/images/ijms-23-10479-g001.png)
IJMS | Free Full-Text | Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against Cancer
![The structural basis of direct glucocorticoid-mediated transrepression | Nature Structural & Molecular Biology The structural basis of direct glucocorticoid-mediated transrepression | Nature Structural & Molecular Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnsmb.2456/MediaObjects/41594_2013_Article_BFnsmb2456_Fig1_HTML.jpg)
The structural basis of direct glucocorticoid-mediated transrepression | Nature Structural & Molecular Biology
![Current Oncology | Free Full-Text | Genomics and Immunomics in the Treatment of Urothelial Carcinoma Current Oncology | Free Full-Text | Genomics and Immunomics in the Treatment of Urothelial Carcinoma](https://www.mdpi.com/curroncol/curroncol-29-00283/article_deploy/html/images/curroncol-29-00283-g001.png)
Current Oncology | Free Full-Text | Genomics and Immunomics in the Treatment of Urothelial Carcinoma
Caution: This is a historical document that may include text and/or images that are deeply offensive, derogatory, and incompatib
![Frontiers | Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy Frontiers | Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy](https://www.frontiersin.org/files/Articles/1036298/fimmu-13-1036298-HTML/image_m/fimmu-13-1036298-g001.jpg)